138 related articles for article (PubMed ID: 8157961)
1. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process.
Takeda K; Moore MW; Dennert G
J Immunol; 1994 May; 152(9):4407-16. PubMed ID: 8157961
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a role for T cell receptors (TCR) in the effector phase of acute bone marrow graft rejection. TCR V beta 5 transgenic mice lack effector cells able to cause graft rejection.
Kikly K; Dennert G
J Immunol; 1992 Dec; 149(11):3489-94. PubMed ID: 1431119
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
4. Evidence for extrathymic development of TNK cells. NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice.
Kikly K; Dennert G
J Immunol; 1992 Jul; 149(2):403-12. PubMed ID: 1385604
[TBL] [Abstract][Full Text] [Related]
5. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
Davenport C; Haile A; Kumar V; Bennett M
J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
[TBL] [Abstract][Full Text] [Related]
6. Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice.
Davenport C; Kumar V; Bennett M
J Immunol; 1995 Oct; 155(8):3742-9. PubMed ID: 7561078
[TBL] [Abstract][Full Text] [Related]
7. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts.
Yankelevich B; Knobloch C; Nowicki M; Dennert G
J Immunol; 1989 May; 142(10):3423-30. PubMed ID: 2654290
[TBL] [Abstract][Full Text] [Related]
8. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
9. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.
Bix M; Liao NS; Zijlstra M; Loring J; Jaenisch R; Raulet D
Nature; 1991 Jan; 349(6307):329-31. PubMed ID: 1987491
[TBL] [Abstract][Full Text] [Related]
10. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
[TBL] [Abstract][Full Text] [Related]
11. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
[TBL] [Abstract][Full Text] [Related]
12. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
Dennert G; Anderson CG; Warner J
J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
[TBL] [Abstract][Full Text] [Related]
13. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
[TBL] [Abstract][Full Text] [Related]
14. Graft rejection by cytolytic T cells. Specificity of the effector mechanism in the rejection of allogeneic marrow.
Nakamura H; Gress RE
Transplantation; 1990 Feb; 49(2):453-8. PubMed ID: 2305471
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of MHC class I-specific cytolytic activity in IL-2-activated NK1+CD3+ cells and evidence of usage of T and NK cell receptors.
Takeda K; Dennert G
Transplantation; 1994 Aug; 58(4):496-504. PubMed ID: 8073519
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.
Koike J; Wakao H; Ishizuka Y; Sato TA; Hamaoki M; Seino K; Koseki H; Nakayama T; Taniguchi M
J Exp Med; 2004 Jan; 199(1):137-44. PubMed ID: 14707119
[TBL] [Abstract][Full Text] [Related]
18. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
19. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
[TBL] [Abstract][Full Text] [Related]
20. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
Sentman CL; Kumar V; Koo G; Bennett M
J Immunol; 1989 Mar; 142(6):1847-53. PubMed ID: 2646375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
